<DOC>
	<DOCNO>NCT00928161</DOCNO>
	<brief_summary>The goal clinical research study learn radiation-induced xerostomia [ RIX ] ( dry mouth ) cause , worsen effect , acid reflux ( heartburn heartburn-like symptom ) head neck cancer ( HNC ) patient receive radiation therapy . Objectives : Primary Objective : Determine radiation induce xerostomia ( RIX ) increase frequency duration acid-reflux re-measured approximately 6-12 week RT ( measure # episode , duration , Reflux Area Index ( RAI ) . Reflux Area ( RA ) sum area curve episode pH &lt; 4 record study unit Ph*minutes . The Reflux area index ( RAI ) RA correct duration study ( RA x 100/study duration ) . Secondary Objectives : 1 . To demonstrate patient undergo RT OPC reflux irradiate field anticipated exacerbate mucositis symptom 2 . Correlate RAI # episode acid reflux salivary flow RT determine radiation induce hyposalivation associate reflux event symptom . 3 . For patient pre-RT pathologic acid reflux , determine RIX lead conversion acid-positive reflux measure approximately 6-12 week RT . 4 . Correlate office indirect laryngoscopy finding ( posterior commissure thickening , cobble-stoning , granuloma , arytenoid erythema edema ) suggestive acid reflux OPC patient pH-probe finding do larynx cancer ( Lewin et al ) 5 . Compare findings patient report outcome ( PRO ) instrument use</brief_summary>
	<brief_title>Reflux Disease Head Neck Cancer Patients Undergoing Radiation Therapy</brief_title>
	<detailed_description>The Study Drug : Dexlansoprazole design block production excess stomach acid cause acid reflux disease . Study Groups : If find eligible take part study , assign 1 2 group , base result screen test . If assign Group 1 , receive study drug , complete study visit radiation therapy , describe . If assign Group 2 , receive Dexlansoprazole . Study Drug Administration : Dexlansoprazole dissolve tablet take mouth . It dissolve tongue . It swallow whole water like regular pill . You take 1 tablet , daily . The study drug take first thing morning empty stomach , eat drink anything water 30-45 minute take study drug . Study Visits : Before schedule radiation therapy , study visit . At visit , follow test procedure perform : - You pH-probe test performed . - You complete PRO questionnaire . - You whole mouth salivary flow ( WMSF ) test . To perform test , chew piece non-flavored gum , spit cup 5 minute . The amount saliva weigh record compare amount record radiation therapy . Radiation Therapy : After complete study visit , schedule radiation therapy . You ask sign separate consent form . Length Study : You remain study begin radiation therapy 6-12 week follow visit complete . After participation study , speak primary doctor long term treatment . If acid reflux disease get bad study , recommend gastrointestinal ( GI ) evaluation treatment . If experience intolerable side effect , take study . Follow-Up Visits : About 6-12 week complete radiation therapy , follow visit . At visit , follow test procedure perform : - You pH-probe test performed . - You complete PRO questionnaire . This investigational study . Dexlansoprazole FDA approve commercially available treatment acid reflux disease . Up 50 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<criteria>1 . Signed informed consent . 2 . Head neck cancer ( HNC ) Oropharynx cancer ( OPC ) patient adults &gt; 18 year age , dispositioned receive curative RT bilateral neck ( include ) parotid irradiation without chemotherapy . 3 . Radiation Therapy ( 3D conformal IMRT ) . 1 . Subjects unable tolerate pHprobe past . 2 . Subjects currently protonpump inhibitor ( PPI ) , daily antacid daily H2 antagonist . 3 . Prior history esophagogastric surgery . 4 . Symptoms active gastrointestinal bleeding ( melena , hematemesis ) . 5 . Known hepatic cirrhosis esophageal varix . 6 . Prior esophageal perforation . 7 . Pregnant lactate woman . Women childbearing potential undergone hysterectomy either positive pregnancy test baseline . Women / men childbearing potential use reliable appropriate contraceptive method ( oral , injectable , implantable hormonal contraceptive ; tubal ligation ; intrauterine device ; barrier contraceptive spermicide ; vasectomized partner ) . 8 . Subjects allergies sensitivity protonpump inhibitor . 9 . Patients complete study followup compliance study protocol . 10 . Patients Plavix ( medically appropriate )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Reflux Disease</keyword>
	<keyword>Acid-reflux</keyword>
	<keyword>Head Neck Cancer</keyword>
	<keyword>HNC</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Radiation-induced xerostomia</keyword>
	<keyword>RIX</keyword>
	<keyword>Dry Mouth</keyword>
	<keyword>Heartburn</keyword>
	<keyword>Dexlansoprazole</keyword>
	<keyword>Prevacid</keyword>
	<keyword>Prevacid Solu-Tab</keyword>
	<keyword>GERD</keyword>
</DOC>